0001127602-16-067704.txt : 20161118
0001127602-16-067704.hdr.sgml : 20161118
20161118101208
ACCESSION NUMBER: 0001127602-16-067704
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161116
FILED AS OF DATE: 20161118
DATE AS OF CHANGE: 20161118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC
CENTRAL INDEX KEY: 0000794172
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 310888197
STATE OF INCORPORATION: OH
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 3471 RIVER HILLS DR
CITY: CINCINNATI
STATE: OH
ZIP: 45244
BUSINESS PHONE: 5132713700
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
FORMER COMPANY:
FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LUEKE MELISSA
CENTRAL INDEX KEY: 0001224663
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14902
FILM NUMBER: 162006665
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-11-16
0000794172
MERIDIAN BIOSCIENCE INC
VIVO
0001224663
LUEKE MELISSA
3471 RIVER HILLS DRIVE
CINCINNATI
OH
45244
1
Exec VP, CFO
Common Stock
163071
D
Stock Options (Right to Buy)
16.85
2016-11-16
4
A
0
10000
0
A
2026-11-16
Common Stock
10000
10000
D
These options are awarded under the 2012 Stock Incentive Plan in connection with increased responsibility as Executive Vice President, Chief Financial Officer, and vest in four equal installments from the date of grant (i.e., 25%
per year until fully vested on November 16, 2020).
/s/ Melissa Lueke
2016-11-18